Myongji Best Plastic Surgery Clinic

Busan Wegovy: Who Can Start a Weekly Weight-Management Injection?

Myongji Best Plastic Surgery Clinic in Myeongji-dong, Gangseo-gu, Busan explains Wegovy eligibility, gradual dose escalation, lifestyle management, and safety considerations.

WriteDateRevision date
Woman receiving a Wegovy weight-management consultation

How does Wegovy support weight management?

Wegovy is a GLP-1 receptor agonist containing semaglutide. It helps reduce food intake by affecting appetite and satiety and is used as a once-weekly subcutaneous injection.

It should be approached as one part of a long-term plan that also addresses nutrition, activity, and sleep, rather than as an injection-only solution.

When may Wegovy be considered?

Adults may generally be considered after medical assessment if their BMI is 30 or higher, or 27 or higher with a weight-related health condition.

  • Weight criteria

    BMI, waist circumference, and weight-related conditions are assessed together.

  • Lifestyle

    Food intake, activity, sleep, and previous weight-loss attempts are reviewed.

  • Medical history

    Tell the clinician about pancreatic or gallbladder disease, gastrointestinal symptoms, and current medications.

  • When use should be avoided

    This includes pregnancy or breastfeeding and a personal or family history of medullary thyroid carcinoma or MEN2.

Do you start with a high dose?

Wegovy starts at a low dose and is increased gradually to reduce gastrointestinal discomfort and assess response. The pace and maintenance dose are adjusted individually.

Key points in a Wegovy dosing plan
ItemGeneral guidanceAdjustment criteria
Dosing cycleGeneral guidanceOnce weekly on the same dayAdjustment criteriaFollow clinical guidance when changing the schedule
Administration siteGeneral guidanceSubcutaneous injection in the abdomen, thigh, or upper armAdjustment criteriaAvoid repeatedly injecting the same site
Starting capacityGeneral guidance0.25mgAdjustment criteriaAssess initial response and gastrointestinal symptoms
Dose escalationGeneral guidanceGradually up to 2.4 mgAdjustment criteriaThe pace may be adjusted if symptoms occur

How does treatment proceed at Myongji Best Plastic Surgery Clinic?

After reviewing weight, BMI, related conditions, and lifestyle, the clinician assesses eligibility and the starting dose, then monitors weight change and adverse effects at follow-ups.

  1. STEP 01

    Health assessment

    Weight-related conditions, medical history, and medications are reviewed.

  2. STEP 02

    Set a lifestyle plan

    Set practical nutrition, activity, and sleep goals.

  3. STEP 03

    Start with a low dose

    Review how to use and store the medicine and select the first dose.

  4. STEP 04

    Step-by-step increase

    Adjust the dose while monitoring effectiveness and discomfort.

  5. STEP 05

    Review the maintenance strategy

    Review a lifestyle plan that also accounts for the period after treatment stops.

When is the response assessed?

Weight change varies with dose, nutrition, activity, and individual response. Early monitoring should record appetite, satiety, and lifestyle changes as well as weight.

A maintenance plan is still needed after reaching a target weight. Do not increase the dose or stop treatment without guidance.

What side effects and precautions should I know?

Common adverse effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Report severe abdominal pain, persistent vomiting, or signs of dehydration.

  • Eating early in treatment

    Eat small portions slowly rather than a large amount at once.

  • Hydration

    If vomiting or diarrhea occurs, monitor hydration to help prevent dehydration.

  • Other medicines

    Report all medicines, including diabetes drugs, and dietary supplements in advance.

  • A sign that medical treatment is needed

    Seek care for persistent severe abdominal pain, repeated vomiting, or a serious allergic reaction.

Eligibility and dose must be decided after a medical assessment. Use the medicine exactly as prescribed.

What should I check before the cost and consultation?

The clinic's published non-covered fee schedule lists Wegovy at KRW 320,000 to 550,000 depending on dose. Total cost varies with dose and treatment duration.

  • Cost by dose

    Published prices range from KRW 320,000 for 0.25 mg to KRW 550,000 for 2.4 mg.

  • Scope of care

    Check whether the fee includes the initial visit, follow-up assessment, and prescription.

  • Dose-escalation plan

    Ask about the expected treatment duration and dose-adjustment criteria.

  • Storage and disposal

    Confirm how to store the pen and safely dispose of used needles.

Non-covered fees may change, so check the latest published schedule and consultation estimate.

REFERENCES

Base material

I checked the hospital's public data and the public medical institution's data together.

  1. Myongji Best Plastic Surgery ClinicWegovy guide
  2. Myongji Best Plastic Surgery ClinicNon-covered fee schedule
  3. European Medicines AgencyWegovy EPAR

Date 2026.10.08Final revision date 2026.10.08